Oragenics, Inc. announced that on May 2, 2021, Dr. Alan Joslyn resigned as Chief Executive Officer, President and director of Oragenics, Inc. to pursue other opportunities. During the interim period before a new CEO is hired, the Board of Directors will provide direction to the Company, with Dr. Frederick Telling transitioning from Chairman of the Board to the newly established position of Executive Chairman, effective immediately. Mr. Sullivan, the Company’s current Chief Financial Officer, will serve as the Company’s interim principal executive officer to address the vacancy created by Dr. Joslyn’s resignation.